Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
06/2001
06/13/2001EP1105124A2 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders
06/13/2001CN1299346A Ureas and carbamates of N-heterocyclic carboxylic acids and carboxylic acid isosteres
06/13/2001CN1299345A Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds
06/13/2001CN1298873A Xiantuopuli-hydrate as inhibitor of angiotonin converzyme
06/13/2001CN1298872A Novel amino pyrroline compound, its prepn. method and pharmaceutical compositions contg. same
06/13/2001CN1067075C Pyrrolo-gyrrolone used as neutrophil elastase inhibitor
06/13/2001CN1067050C Method for prodn. of 3-alkoxy-2-substituted phenmethyl acid or ester thereof
06/12/2001US6245811 Fatty acid esters as bioactive compounds
06/12/2001US6245801 Branched alkyl pyrrolidine-3-carboxylic acids
06/12/2001CA2072123C Inhibitors of purine nucleoside phosphorylase
06/11/2001WO2001044230A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors
06/11/2001CA2393310A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors
06/07/2001WO2001040185A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
06/07/2001WO2001040181A1 Acryloyl peptidic derivatives, process for their preparation and their use as antitumor agents
06/07/2001WO2001040180A2 N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents
06/07/2001WO2001040163A1 A PROCESS FOR PRODUCING AMINE COMPOUND WITH t-BUTOXYCARBONYL GROUP
06/07/2001WO2001039779A1 A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
06/07/2001WO2001039769A1 Hypoglycemics comprising organic zinc (ii) complexes
06/07/2001WO2001010894A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
06/07/2001WO1999063940A3 INHIBITORS OF H+K+-ATPase
06/07/2001CA2395094A1 Acryloyl peptidic derivatives, process for their preparation and their use as antitumor agents
06/07/2001CA2392713A1 Novel antidiabetic agents
06/07/2001CA2389368A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
06/06/2001EP1104754A1 Novel sulfonyl derivatives
06/06/2001EP1104299A2 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders
06/06/2001EP1104298A2 Heterocyclic thioesters or ketones for vision and memory disorders
06/06/2001CN1298390A Arylphenyl-substituted cyclic keto-enols
06/06/2001CN1298389A Cyclic amino compounds
06/06/2001CN1298387A Process for the preparation of methyl (2S)-2-[(3R)-3-CN-[tert-butyloxycarbonyl]-amino)-2-oxopyrrolidin-1-yL] propionate
06/06/2001CN1298299A Antibacterial agents
06/06/2001CN1066754C Thermoplastic resin composition and its molding method
06/06/2001CN1066713C Stilbene derivatives and pharmaceutical composition containing them
06/06/2001CN1066712C Prolineamide derivatives
06/05/2001US6242645 Biological activity enhancer, deoxofluorination agent of interest in medicinal and agrochemical products
06/05/2001US6242644 N-(4-carbamimidoyl-phenyl)-glycine derivatives
06/05/2001US6242613 Such as chlorofenapyr used as insecticdes and pesticides; crystals that do not increase in size during storage
06/05/2001US6242609 Ammonium trihalide for halogenation of color couplers and silver halide emulsions
06/05/2001US6242500 Intercalates and exfoliates formed with long chain (C6+) or aromatic matrix polymer-compatible monomeric, oligomeric or polymeric intercalant compounds, and composite materials containing same
06/05/2001US6242494 Angiogenesis inhibitors, antitumor agents, diabetic retinopathy, and antiinflammatory agents
06/05/2001US6242476 Leukotriene A4 hydrolase inhibitors
06/05/2001US6242475 Pesticidal 1-polyarylpyrazoles
06/05/2001US6242438 3-Azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
06/05/2001US6242432 Antihypertensive activity, antihypersensitive activity; treatment of cardiovascular disease
06/05/2001US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
05/2001
05/31/2001WO2001038325A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
05/31/2001WO2001038309A1 β-AMINO ACID-, ASPARTIC ACID- AND DIAMINOPROPIONIC-BASED INHIBITORS OF FACTOR Xa
05/31/2001WO2001038304A1 Heterocyclic ketone and thioester compounds and uses
05/31/2001WO2001038303A2 Vitamin d analogues
05/31/2001WO2001037826A1 Npyy5 antagonists
05/31/2001WO2000042071A3 Compounds and methods to inhibit or augment an inflammatory response
05/31/2001WO1999064041A9 Multibinding agents that modulate nmda receptors
05/31/2001US20010002402 Composition for repilling and deterring pests
05/31/2001CA2392576A1 .beta.-amino acid-, aspartic acid- and diaminopropionic-based inhibitors of factor xa
05/31/2001CA2391575A1 Heterocyclic ketone and thioester compounds and uses
05/31/2001CA2390923A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
05/30/2001EP1103549A1 Photoprotective cosmetic compositions containing aminoamidine derivatives and uses thereof
05/30/2001EP1103261A1 Remedies or preventives for intractable epilepsy
05/30/2001EP1102756A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
05/30/2001EP1102745A1 A process for the preparation of zofenopril calcium salt
05/30/2001EP1102743A1 Amide derivatives which are useful as cytokine inhibitors
05/30/2001EP1102739A1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders
05/30/2001EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors
05/30/2001EP1102592A1 Coumarin and related aromatic-based polymeric prodrugs
05/30/2001EP0641320B1 Substituted (s)-3-phenylpiperidine derivatives, their preparation and their use as dopamine autoreceptor antagonists
05/30/2001CN1297436A Substd. pyrrolidine hydroxamate metalloprotease inhibitors
05/30/2001CN1297435A Method for producing enantiomer-free N-methyl-N-[(1S)-1-phenyl-2-[(3S)-3-hydroxypyrrolidine-1-y1)ethyl]-2, 2-diphenyl acetamide
05/29/2001US6239306 Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulations
05/29/2001US6239175 Carbamoyloxy derivatives of mutiline and their use as antibacterials
05/29/2001US6239173 Antiinflammatory, antipyretic, analgesic, and antiarthritic agents
05/29/2001US6239163 Salt of (2R,3R,4R)-3,4-dihydroxy-2-hydroxymethylpyrrolidine
05/29/2001US6239154 Arylacetamides, agonists at kappa opioid receptors.
05/29/2001US6239151 Compounds as inhibitor of tumor necrosis factor alpha release
05/29/2001US6239148 Treatment of painful, hyperalgesic and/or inflammatory conditions in which c-fibers play a role by eliciting neurogenic pain, insulin resistance in diabetes mellitus or aging, inhibit insulin antagonizing peptide,
05/29/2001US6239146 Neurotrophic difluoroamide agents
05/29/2001US6239145 Usable in acquiring information about active oxygen or in vivo free radicals as biological images such as magnetic resonance images or magnetoencephalograms;
05/29/2001US6238752 Diamino compounds, polyamic acids, polyimides, liquid crystal aligning films using said polyimide films and liquid crystal display devices using said aligning films
05/29/2001CA2325783A1 Ultraviolet-protecting cosmetic compounds containing amino- amidine derivatives and uses
05/25/2001WO2001036404A1 Compounds and methods
05/25/2001WO2001036403A1 Urea derivatives as anti-inflammatory agents
05/25/2001WO2001036384A1 Polymorphic form of atorvastatin calcium
05/25/2001WO2001036376A1 Novel phenylalanine derivatives
05/25/2001WO2001036375A1 Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders
05/25/2001WO2000039081A3 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/25/2001WO1999033841B1 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action
05/24/2001US20010001802 Process for preparing 3-(7-amidino-2-naphthyl)-2-phenylpropionic acid derivatives
05/24/2001US20010001799 Anticoagulant
05/23/2001EP1101756A1 Aminopyrrolidine derivatives, processes for their preparation and pharmaceutical compositions comprising them
05/23/2001EP1101755A1 Anthranilic acid derivatives
05/23/2001EP1100778A1 Oxidised sulfurated distamycin derivatives, process for preparing them, and their use as antitumor agents
05/23/2001EP1100777A1 Sulfurated distamycin derivatives, process for preparing them, and their use as antitumor agents
05/23/2001EP1100763A1 Diketoacid-derivatives as inhibitors of polymerases
05/23/2001EP1100519A1 Multibinding agents that modulate nmda receptors
05/23/2001EP1100504A2 Pharmaceutical compositions and their uses for treatment of demyelinating disorders
05/23/2001EP1100503A2 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications
05/23/2001EP1100498A1 Heterocyclic sulphonamide derivatives
05/23/2001EP1100495A1 Propenamides as ccr5 modulators
05/23/2001EP0689536B1 Naphthalene derivatives
05/23/2001CN1296478A Histamine H3 receptor ligands
05/22/2001US6235927 Process for the separation of a mixture of enantiomers
05/22/2001US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis